The Extended Generic Activity Model (EGAM)
Por um escritor misterioso
Last updated 26 abril 2025


Accelerated Brain Volume Loss Caused by Anti–β-Amyloid Drugs

The type II secretion system: biogenesis, molecular architecture

The Extended Generic Activity Model (EGAM)

Mind the Gap! A Journey towards Computational Toxicology

Towards a synthetic cell cycle

Connecting sequence features within the disordered C-terminal

Characterization of Shiga toxin‐producing Escherichia coli

Research Activity Cycle Overview: Business Continuity Manager Role

Amid shortage of generic Adderall, frustration builds as demand

Molecular responses to acute exercise and their relevance for

The Extended Generic Activity Model (EGAM)

Frontiers SWADESH: a multimodal multi-disease brain imaging and

Treatment-induced and pre-existing anti-PEG antibodies: Prevalence